Literature DB >> 3371351

The effect of poly(ADP-ribose) on interactions of DNA with histones H1, H3 and H4.

J Wesierska-Gadek1, G Sauermann.   

Abstract

The competition between poly(ADP-ribose) and DNA for binding of the histones H1, H3 and H4 was studied, using a membrane filter-binding test. Poly(ADP-ribose) differently affected the interaction between DNA and the individual histones. While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1. Moreover, preformed complexes were correspondingly affected by the addition of competing polynucleotides, thereby also indicating the reversibility of complex formation. The competition capacity of DNA for histone H4 binding did not depend on DNA size. Competition experiments with poly(A) also indicated that poly(ADP-ribose) preferentially affected DNA-histone H4 interaction. The significance of the differing binding properties is discussed with regard to the possible molecular function of poly(ADP-ribose), especially with regard to its potential effect on nucleosome structure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371351     DOI: 10.1111/j.1432-1033.1988.tb14051.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

Review 1.  Histone shuttling by poly ADP-ribosylation.

Authors:  F R Althaus; L Höfferer; H E Kleczkowska; M Malanga; H Naegeli; P L Panzeter; C A Realini
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

2.  Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase.

Authors:  T Miyamoto; T Kakizawa; K Hashizume
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 3.  Reprogramming cellular events by poly(ADP-ribose)-binding proteins.

Authors:  Jana Krietsch; Michèle Rouleau; Émilie Pic; Chantal Ethier; Ted M Dawson; Valina L Dawson; Jean-Yves Masson; Guy G Poirier; Jean-Philippe Gagné
Journal:  Mol Aspects Med       Date:  2012-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.